AprilBio Amends Rights Issue Disclosure – Changes Third-Party Allottee to SPC, Terms Unchanged
This amendment changes one of the third-party allottees from IMM Asset Management to the special purpose company IMM Healthcare No. 8, but all key terms of the rights issue remain unchanged.
With the payment of subscription on July 23, 2026, 4,095,456 new shares are issued, resulting in approximately 17.5% dilution relative to existing shares. The largest shareholder will change to IMM Healthcare No. 8.
The new shares are subject to a one-year lock-up, and the proceeds will be fully used for R&D. The funding structure involves credible institutional investors including IMM Asset Management, KDB Capital, and the National Pension Service.
[AI Summary]This amendment finalizes the structural details of the capital increase without altering the original terms, resulting in a neutral impact on shareholder value. However, the 17.5% dilution remains a tangible burden.
KOSDAQ Filing Information
[Correction of Description] Report on Major Events (Decision on Paid-in Capital Increase)